Amplify Therapeutics ApS — Credit Rating and Financial Key Figures
CVR number: 43803999
Ole Maaløes Vej 3, 2200 København N
Income statement (kDKK)
2023 | 2024 | |
|---|---|---|
| Fiscal period length | 12 | 12 |
| Net sales | ||
| Gross profit | -1 558.70 | -4 961.50 |
| Employee benefit expenses | - 825.44 | -3 318.95 |
| EBIT | -2 384.14 | -8 280.45 |
| Other financial income | 2.80 | 16.88 |
| Other financial expenses | -97.70 | - 513.89 |
| Pre-tax profit | -2 479.04 | -8 777.46 |
| Income taxes | 526.32 | 1 582.60 |
| Net earnings | -1 952.72 | -7 194.85 |
Assets (kDKK)
2023 | 2024 | |
|---|---|---|
| Intangible assets total | ||
| Tangible assets total | ||
| Investments total | ||
| Long term receivables total | ||
| Inventories total | ||
| Current other receivables | 278.46 | 163.84 |
| Current deferred tax assets | 526.32 | 1 582.60 |
| Short term receivables total | 804.79 | 1 746.44 |
| Cash and bank deposits | 1 824.90 | 4 198.29 |
| Cash and cash equivalents | 1 824.90 | 4 198.29 |
| Balance sheet total (assets) | 2 629.68 | 5 944.73 |
Equity and liabilities (kDKK)
2023 | 2024 | |
|---|---|---|
| Share capital | 40.00 | 40.00 |
| Retained earnings | -1 952.72 | |
| Profit of the financial year | -1 952.72 | -7 194.85 |
| Shareholders equity total | -1 912.72 | -9 107.57 |
| Non-current deferred tax liabilities | 4 097.64 | 14 597.42 |
| Non-current liabilities total | 4 097.64 | 14 597.42 |
| Current loans from credit institutions | 17.15 | |
| Current trade creditors | 257.08 | 80.01 |
| Other non-interest bearing current liabilities | 121.02 | 357.73 |
| Accruals and deferred income | 66.67 | |
| Current liabilities total | 444.76 | 454.88 |
| Balance sheet total (liabilities) | 2 629.68 | 5 944.73 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.